The Neko Health scan results are, depending on your constitution, either a relief or a very specific kind of dread: a 15-minute appointment that ends with data on your heart age, metabolic health and skin, and, in some cases, a warning that something is already going wrong. Having paired that data with an Oura ring’s continuous tracking, one writer found the combination produced an unusually clear picture of biological age and sickness risk, the sort of picture your GP, working from a ten-minute appointment and a blood pressure cuff, rarely has time to draw.
What the Neko Health scan results actually measure
The premise of Neko Health is straightforward, even if the technology behind it is not. According to British Vogue, the scan takes just 15 minutes and costs £299. In that quarter of an hour, the system works through a full-body assessment: cardiovascular markers, skin analysis, metabolic data, body composition. The output is a dashboard of results that maps where your body currently sits against where it should be for your age, and where the trajectories are heading.
The Oura ring enters the picture as a longitudinal companion. Where the Neko scan gives a single detailed cross-section, the ring supplies the time-series data, resting heart rate trends, heart rate variability, sleep staging, body temperature deviation. Used together, they answer different questions. The scan asks: what is the state of this body right now? The ring asks: what has this body been doing, and where is it drifting?
The writer’s experience produced one finding that cuts through any enthusiasm for the technology: a warning, based on the data, that illness was imminent. The physiological signals were there before the symptoms. Whether that constitutes useful medicine or an anxiety-inducing data point is, frankly, a question the industry has not yet resolved.
The broader picture: who actually needs this scan
Neko was co-founded by two non-doctors, one of whom is Spotify founder Daniel Ek, according to British Vogue. That detail has followed the company since its launch, used variously as a criticism (tech entrepreneurs diagnosing the body) and as context (people willing to fund genuinely novel infrastructure). The clinics have the aesthetic of the former: clean lines, minimal waiting, the appointment delivered with the efficiency of a software product rather than a GP surgery.
What the company’s own first-year data suggests is harder to dismiss on aesthetic grounds. According to Harper’s Bazaar UK, of all the people scanned in Neko’s first year of operation, 14.1 per cent required medical attention, while 1 per cent received potentially life-saving treatment for serious conditions including cardiovascular disease, severe metabolic diseases and skin cancer. Those are not vanity-wellness numbers. They suggest a technology that is, at least for a portion of people who use it, catching something the standard healthcare pathway had not.
The £299 price point sits in an interesting position in the market. It is not cheap, but it is not inaccessible in the way that private MRI suites or executive health programmes at London hospitals tend to be. The question of who the scan is actually for (the worried well, the genuinely at-risk, the data-curious) remains open. The 1 per cent figure argues for the latter category existing in larger numbers than we typically assume.
Pairing the scan with wearable data is where the real methodological interest lies. Wearables have accumulated an enormous amount of longitudinal health data on their wearers, but interpreting that data without a clinical baseline has always been the limitation. A resting heart rate of 58 bpm means something different depending on your cardiac structure, your body composition and your metabolic baseline. The Neko scan, in theory, supplies those anchors.
The writer’s conclusion, that the warning of incoming illness proved accurate, is the kind of anecdote that is impossible to generalise from and difficult to ignore. Neko has opened bookings across its UK clinics for anyone who wants to find out which category they fall into.
